HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carme de Bolós Selected Research

Lewis Blood Group Antigens

12/2011Down-regulation of FUT3 and FUT5 by shRNA alters Lewis antigens expression and reduces the adhesion capacities of gastric cancer cells.
2/2011Regulation of glycosyltransferases and Lewis antigens expression by IL-1β and IL-6 in human gastric cancer cells.
7/2007Changes in the invasive and metastatic capacities of HT-29/M3 cells induced by the expression of fucosyltransferase 1.
11/2002Differences in the O-glycosylation patterns between lung squamous cell carcinoma and adenocarcinoma.
1/2002The expression of human FUT1 in HT-29/M3 colon cancer cells instructs the glycosylation of MUC1 and MUC5AC apomucins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carme de Bolós Research Topics

Disease

8Neoplasms (Cancer)
09/2015 - 11/2002
7Adenocarcinoma
07/2021 - 11/2002
5Stomach Neoplasms (Stomach Cancer)
09/2014 - 10/2008
3Carcinogenesis
09/2014 - 02/2011
3Neoplasm Metastasis (Metastasis)
08/2013 - 02/2011
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2016 - 09/2015
2Inflammation (Inflammations)
09/2015 - 02/2011
2Colonic Neoplasms (Colon Cancer)
07/2007 - 01/2002
1Barrett Esophagus (Barrett's Esophagus)
07/2021
1Infections
09/2014
1Hyperplasia
01/2007
1Endometrial Hyperplasia
01/2007
1Endometrioid Carcinoma
01/2007
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2002
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2002

Drug/Important Bio-Agent (IBA)

5CytokinesIBA
09/2015 - 10/2008
5Lewis Blood Group AntigensIBA
12/2011 - 01/2002
4Sialyl Lewis X AntigenIBA
09/2015 - 07/2007
4FucosyltransferasesIBA
08/2013 - 07/2007
3GlycosyltransferasesIBA
09/2015 - 11/2002
3Interleukin-6 (Interleukin 6)IBA
09/2014 - 10/2008
3SialyltransferasesIBA
08/2013 - 03/2005
3MucinsIBA
10/2008 - 11/2002
2Messenger RNA (mRNA)IBA
07/2021 - 03/2005
2AntigensIBA
09/2015 - 07/2007
2CarbohydratesIBA
03/2005 - 11/2002
1MicroRNAs (MicroRNA)IBA
07/2021
1Biomarkers (Surrogate Marker)IBA
01/2016
1Glycoproteins (Glycoprotein)IBA
01/2016
1Polysaccharides (Glycans)IBA
09/2015
1Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA
09/2015
1InterleukinsIBA
10/2013
1NF-kappa B (NF-kB)IBA
10/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2013
1beta-Galactoside alpha-2,3-SialyltransferaseIBA
08/2013
1Hyaluronic Acid (Hyaluronan)IBA
12/2011
1E-SelectinIBA
12/2011
1Small Interfering RNA (siRNA)IBA
12/2011
1Glycoside Hydrolases (Endoglycosidases)IBA
02/2010
1fagomineIBA
02/2010
1AntibodiesIBA
01/2007
1AmylasesFDA Link
11/2002
1Periodic AcidIBA
11/2002